What is RADNOSTIX INC's earnings per share (EPS)?

RADNOSTIX INC (INIS) reported diluted earnings per share of $0.00 for fiscal year 2025. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

RADNOSTIX INC (INIS) Financials

INIS

Trailing 12 months to June 30, 2026

Revenue $11.2M -23.7% YoY

Net Income -$2.9M -2436.7% YoY

EPS (Diluted) $0.00 YoY not available

Free Cash Flow -$925K -3244.2% YoY

Market Cap $23.8M as of Oct 15, 2026

Price / Sales 2.1x on $11.2M revenue, trailing 12 months to June 30, 2026

Price / Earnings n/m net loss, so no earnings multiple, trailing 12 months to June 30, 2026

Price / Book 12.6x on $1.9M equity, Q2 FY2026

A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 15, 2026; every other figure is from the SEC filings on this page. Not financial advice.

Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Aug 12, 2026 Currency USD FYE December

Newest figures come from the 10-Q for Q2 FY2026, filed Aug 12, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the INIS SEC filings page.

RADNOSTIX INC (INIS) reported $11.2M in revenue over the twelve months to Jun 30, 2026, down 23.7% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI INIS FY2025 2026-10-03

The business can produce operating cash, but 2025’s margin reversal and greater balance-sheet pressure made profitability fragile.

Operating margin moved from 0.1% in FY2024 to -7.3% in FY2025. Gross margin also fell from 62.2% to 58.9%, indicating that weaker earnings reflected both reduced sales volume and less favorable economics per sales dollar.

FY2025 produced operating cash flow of $620K despite a net loss of $908K, so reported earnings and cash generation diverged materially. After $534K of capital spending, only $86K remained as free cash flow, showing that reinvestment absorbed most operating cash rather than leaving a broad cash surplus.

The balance sheet became less flexible: total liabilities rose to $14.1M while equity fell to $3.7M. The current ratio declined to 1.2x from 1.5x in FY2024, meaning the cushion of current assets over near-term obligations narrowed as profitability weakened.

Financial Health Signals

Financial health score not available

RADNOSTIX INC does not currently provide enough eligible data for a peer-relative financial health score, so none is published. The signals and metrics below are current.

Altman Z-Score Distress

-8.45

RADNOSTIX INC scores -8.45, below the 1.81 distress threshold. The score is driven primarily by a large market capitalization ($23.8M) relative to total liabilities ($14.1M). This indicates elevated financial distress risk and warrants close attention to liquidity and debt levels.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Weak

3/9

RADNOSTIX INC passes 3 of 9 financial strength tests. 2 of 4 profitability signals pass, 1 of 3 leverage/liquidity signals pass, neither operating efficiency signal passes.

Earnings Quality Mixed

N/A

RADNOSTIX INC reported a net loss of $908K while generating $620K in operating cash flow. Operations generated cash despite the loss, but with no positive earnings behind it, the ratio between the two carries no quality signal.

Interest Coverage At Risk

N/A

RADNOSTIX INC reported an operating loss of $956K against $339K in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$2.7M

YoY-26.9%

QoQ+12.3%

5Y CAGR-0.6%

10Y CAGR+4.6%

RADNOSTIX INC generated $2.7M in revenue in Q2 2026. This represents a decrease of 26.9% from the same quarter a year earlier. Against the prior quarter it is up 12.3%.

EBITDA

-$727K

YoY-2051.1%

QoQ+39.4%

RADNOSTIX INC's EBITDA was -$727K in Q2 2026, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 2051.1% from the same quarter a year earlier. Against the prior quarter it is up 39.4%.

Net Income

-$882K

YoY-448.6%

QoQ+34.6%

RADNOSTIX INC reported -$882K in net income in Q2 2026. This represents a decrease of 448.6% from the same quarter a year earlier. Against the prior quarter it is up 34.6%.

EPS (Diluted)

$0.00

RADNOSTIX INC earned $0.00 per diluted share (EPS) in Q2 2026.

Cash & Balance Sheet

Free Cash Flow

-$614K

YoY-341.5%

QoQ-121.0%

RADNOSTIX INC recorded an outflow of $614K in free cash flow in Q2 2026, representing a cash shortfall after capex. This represents a decrease of 341.5% from the same quarter a year earlier. Against the prior quarter it is down 121.0%.

Cash & Debt

$1.2M

YoY-35.7%

QoQ-11.2%

5Y CAGR+18.2%

10Y CAGR+10.8%

RADNOSTIX INC held $1.2M in cash as of Q2 2026; long-term debt is not reported for that period.

Shares Outstanding

529M

YoY+0.2%

QoQ0.0%

5Y CAGR+1.1%

10Y CAGR+2.8%

RADNOSTIX INC had 529M shares outstanding in Q2 2026. This represents an increase of 0.2% from the same quarter a year earlier. It is unchanged from the prior quarter.

Dividends Per Share

Not reported for Q2 2026.

Margins & Returns

Gross Margin

50.9%

YoY-7.7pp

QoQ+2.5pp

5Y change-6.7pp

10Y change+5.3pp

RADNOSTIX INC's gross margin was 50.9% in Q2 2026, indicating the percentage of revenue retained after direct costs. This is down 7.7 percentage points from the same quarter a year earlier. Against the prior quarter it is up 2.5 percentage points.

Operating Margin

-31.2%

YoY-27.5pp

QoQ+23.8pp

5Y change-31.8pp

10Y change-10.4pp

RADNOSTIX INC's operating margin was -31.2% in Q2 2026, reflecting core business profitability. This is down 27.5 percentage points from the same quarter a year earlier. Against the prior quarter it is up 23.8 percentage points.

Net Margin

-33.0%

YoY-28.6pp

QoQ+23.7pp

5Y change-26.4pp

10Y change-6.8pp

RADNOSTIX INC's net profit margin was -33.0% in Q2 2026, showing the share of revenue converted to profit. This is down 28.6 percentage points from the same quarter a year earlier. Against the prior quarter it is up 23.7 percentage points.

Return on Equity

-46.6%

YoY-42.8pp

QoQ+4.3pp

5Y change+24.1pp

RADNOSTIX INC's ROE was -46.6% in Q2 2026, measuring profit generated per dollar of shareholder equity. This is down 42.8 percentage points from the same quarter a year earlier. Against the prior quarter it is up 4.3 percentage points.

Capital Allocation

R&D Spending

$115K

YoY+11.8%

QoQ-23.0%

5Y CAGR+9.8%

10Y CAGR-1.6%

RADNOSTIX INC invested $115K in research and development in Q2 2026. This represents an increase of 11.8% from the same quarter a year earlier. Against the prior quarter it is down 23.0%.

Capital Expenditures

YoY-100.0%

QoQ-100.0%

RADNOSTIX INC reported no capital expenditure in Q2 2026. This represents a decrease of 100.0% from the same quarter a year earlier. Against the prior quarter it is down 100.0%.

Share Buybacks

Not reported for Q2 2026.

INIS Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

INIS quarterly income statement

Metric	TTM	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Revenue	$11.2M	$13.1M-6.0%	$13.9M+13.3%	$12.3M+9.7%	$11.2M+15.7%	$9.7M+3.2%	$9.4M+4.6%	$9.0M-13.6%	$10.4M+39.7%	$7.4M+13.3%	$6.6M-7.2%	$7.1M-6.3%	$7.5M	N/A	N/A	N/A
Cost of Revenue	$5.2M	$5.4M+2.2%	$5.3M+7.4%	$4.9M-0.1%	$4.9M+24.7%	$3.9M+0.5%	$3.9M-9.0%	$4.3M-24.5%	$5.7M+35.8%	$4.2M	N/A	N/A	N/A	N/A	N/A	N/A
Gross Profit	$6.0M	$7.7M-10.9%	$8.6M+17.2%	$7.4M+17.3%	$6.3M+9.6%	$5.7M+5.1%	$5.5M+17.0%	$4.7M-0.5%	$4.7M+44.9%	$3.2M+13.8%	$2.8M+5.2%	$2.7M-9.2%	$3.0M+17.4%	$2.5M-4.4%	$2.7M-22.4%	$3.4M
R&D Expenses	$490K	$436K-28.6%	$611K+5.8%	$577K+8.2%	$534K+96.4%	$272K+23.8%	$219K-16.7%	$263K-43.8%	$469K+24.4%	$377K-26.3%	$511K-37.8%	$821K+77.0%	$464K-34.3%	$706K-28.7%	$990K-41.6%	$1.7M
SG&A Expenses	$3.7M	$3.7M-6.9%	$4.0M+13.1%	$3.5M-0.6%	$3.6M+3.2%	$3.5M+22.3%	$2.8M+17.8%	$2.4M+9.1%	$2.2M-21.7%	$2.8M+36.8%	$2.1M+24.6%	$1.6M+2.4%	$1.6M-24.3%	$2.1M+9.3%	$1.9M-4.2%	$2.0M
Operating Income	-$2.9M	-$956K-13955.8%	$7K+100.9%	-$776K+35.5%	-$1.2M-76.7%	-$681K-63.8%	-$416K+25.5%	-$558K-92.5%	-$290K+86.0%	-$2.1M-37.4%	-$1.5M-4.3%	-$1.4M-83.4%	-$786K+62.5%	-$2.1M+3.9%	-$2.2M+35.2%	-$3.4M
EBITDA	N/A	-$554K-235.7%	$408K+195.7%	-$426K+48.6%	-$829K-732.7%	-$100K+13.9%	-$116K+60.2%	-$290K-1199.0%	-$22K+98.8%	-$1.8M-42.9%	-$1.3M-3.7%	-$1.2M-135.6%	-$522K+69.0%	-$1.7M+4.8%	-$1.8M+40.6%	-$3.0M
Interest Expense	$342K	$339K+3.2%	$329K-0.9%	$332K-46.0%	$614K-22.4%	$792K+1.2%	$782K+44.4%	$541K+15.1%	$470K-7.8%	$510K+7.5%	$474K-4.8%	$498K-46.8%	$937K+99.7%	$469K+130.4%	$204K-92.8%	$2.8M
Income Tax	N/A	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0+100.0%	-$837K-9.9%	-$762K+62.3%	-$2.0M
Net Income	-$2.9M	-$908K-10690.2%	$9K+101.0%	-$869K-386.6%	$303K+133.6%	-$902K-141.0%	$2.2M+244.6%	-$1.5M-80.3%	-$845K+77.5%	-$3.8M-99.9%	-$1.9M-3.3%	-$1.8M-17.7%	-$1.5M+37.2%	-$2.5M-9.9%	-$2.2M+62.3%	-$6.0M
EPS (Basic)	N/A	$0.00	$0.00	$0.00	$0.00	$0.00-100.0%	$0.01	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
EPS (Diluted)	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00-100.0%	$0.01	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Diluted Shares (Avg)	N/A	527M+0.9%	522M+0.9%	518M+1.4%	511M+6.9%	478M+10.8%	431M+3.1%	418M	N/A	N/A	N/A	N/A	N/A	N/A	N/A	335M

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Revenue	$2.7M-26.9%	$2.4M-26.6%	$2.9M-25.7%	$3.3M-16.5%	$3.7M+15.3%	$3.2M+11.5%	$3.9M+24.0%	$3.9M+34.5%
Cost of Revenue	$1.3M-13.3%	$1.2M+1.7%	$1.3M-17.5%	$1.3M-9.3%	$1.5M+31.4%	$1.2M+16.2%	$1.6M+34.0%	$1.5M+31.0%
Gross Profit	$1.4M-36.5%	$1.2M-43.4%	$1.6M-31.4%	$1.9M-20.8%	$2.1M+6.1%	$2.0M+8.9%	$2.3M+17.9%	$2.4M+36.6%
R&D Expenses	$115K+11.8%	$149K+39.8%	$87K-28.3%	$139K+24.1%	$103K-45.6%	$107K-43.3%	$121K-28.3%	$112K+11.7%
SG&A Expenses	$898K-17.2%	$1.0M+16.4%	$955K+9.1%	$822K-24.1%	$1.1M+3.6%	$871K-13.2%	$875K-5.4%	$1.1M+27.6%
Operating Income	-$834K-518.7%	-$1.3M-1914.9%	-$575K-310.1%	-$181K-201.0%	-$135K+25.1%	-$65K+75.6%	$274K+401.3%	$180K+158.0%
EBITDA	-$727K-2051.1%	-$1.2M-3743.7%	-$472K-226.4%	-$81K-128.8%	-$34K+58.3%	$33K+120.0%	$373K+13720.4%	$280K+225.8%
Interest Expense	$84K+1.5%	$85K+1.2%	$86K+2.8%	$86K+5.4%	$83K+1.6%	$84K+3.1%	$84K-0.3%	$82K-0.6%
Net Income	-$882K-448.6%	-$1.3M-1096.2%	-$431K-275.3%	-$204K-235.5%	-$161K+31.1%	-$113K+26.8%	$246K+325.4%	$150K+143.1%
EPS (Basic)	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
EPS (Diluted)	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Diluted Shares (Avg)	529M+0.3%	528M+0.8%	N/A	528M+0.9%	527M+0.9%	524M+0.8%	N/A	523M+0.9%

Not reported in any period shown, so not listed: Income Tax.

INIS Balance Sheet

INIS quarterly balance sheet

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Total Assets	$17.8M+3.9%	$17.2M+1.5%	$16.9M+4.1%	$16.2M-0.5%	$16.3M-4.5%	$17.1M+12.1%	$15.3M+17.4%	$13.0M+8.2%	$12.0M+5.5%	$11.4M+1.2%	$11.2M+2.7%	$11.0M-8.8%	$12.0M-0.3%	$12.0M+0.9%	$11.9M
Current Assets	$4.6M-7.2%	$5.0M-13.4%	$5.8M+0.3%	$5.7M+76.2%	$3.3M-18.4%	$4.0M-36.8%	$6.3M+33.6%	$4.7M+26.9%	$3.7M+12.9%	$3.3M+5.2%	$3.1M+14.4%	$2.7M-23.7%	$3.6M+4.4%	$3.4M-23.4%	$4.5M
Cash & Equivalents	$1.7M-12.9%	$1.9M-27.6%	$2.7M+13.1%	$2.4M+400.3%	$475K-57.3%	$1.1M+93.4%	$575K-30.5%	$828K+102.3%	$409K+30.1%	$315K-21.0%	$398K-28.8%	$559K+22.4%	$456K-16.4%	$546K-74.0%	$2.1M
Short-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0
Inventory	$875K+6.6%	$821K-11.5%	$927K+24.5%	$745K-19.5%	$925K+10.4%	$838K-75.5%	$3.4M+23.8%	$2.8M+41.7%	$2.0M+32.2%	$1.5M+32.8%	$1.1M+6.0%	$1.0M-29.0%	$1.5M+15.1%	$1.3M-12.3%	$1.5M
Accounts Receivable	$1.4M-6.8%	$1.5M+3.5%	$1.5M-8.0%	$1.6M+87.1%	$854K+7.2%	$796K-9.1%	$876K+6.8%	$820K+29.2%	$635K-18.0%	$774K-28.6%	$1.1M+38.4%	$784K-25.1%	$1.0M+21.4%	$862K+7.3%	$803K
Long-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0
Goodwill	$1.4M0.0%	$1.4M0.0%	$1.4M0.0%	$1.4M0.0%	$1.4M0.0%	$1.4M0.0%	$1.4M0.0%	$1.4M+0.6%	$1.4M	$0	N/A	$1.4M	N/A	N/A	N/A
Total Liabilities	$14.1M+10.4%	$12.8M-0.4%	$12.9M+8.1%	$11.9M-12.5%	$13.6M-4.3%	$14.2M-7.5%	$15.4M+19.7%	$12.8M+10.1%	$11.7M+21.1%	$9.6M+25.6%	$7.7M+9.8%	$7.0M-2.6%	$7.2M+19.8%	$6.0M+32.8%	$4.5M
Current Liabilities	$4.0M+19.4%	$3.3M+1.7%	$3.3M-6.9%	$3.5M-28.8%	$4.9M-12.8%	$5.7M-30.8%	$8.2M+13.8%	$7.2M+30.5%	$5.5M-26.6%	$7.5M+202.1%	$2.5M-4.4%	$2.6M+54.4%	$1.7M-11.0%	$1.9M-40.2%	$3.2M
Non-Current Liabilities	$10.2M+7.2%	$9.5M-1.1%	$9.6M+14.4%	$8.4M-3.2%	$8.7M+1.3%	$8.5M+19.0%	$7.2M+27.3%	$5.6M-8.2%	$6.1M+190.9%	$2.1M-59.2%	$5.2M+18.3%	$4.4M-20.2%	$5.5M+34.1%	$4.1M+206.3%	$1.3M
Long-Term Debt	$1.9M-12.5%	$2.2M+7.9%	$2.0M+22.0%	$1.7M-14.5%	$2.0M+20.2%	$1.6M-40.6%	$2.7M+319.6%	$655K+27.0%	$516K-87.0%	$4.0M+9.9%	$3.6M+1668.1%	$205K-19.6%	$254K	$0	N/A
Total Equity	$3.7M-15.1%	$4.3M+7.7%	$4.0M-7.0%	$4.3M+59.0%	$2.7M+376.1%	$574K+126.2%	-$2.2M-36.3%	-$1.6M-30.4%	-$1.2M-172.1%	$1.7M-51.5%	$3.5M-9.9%	$3.9M-18.4%	$4.8M-20.0%	$6.0M-18.2%	$7.3M
Retained Earnings	-$128.2M-0.7%	-$127.3M0.0%	-$127.3M-0.7%	-$126.5M+0.2%	-$126.8M-0.7%	-$125.9M+1.7%	-$128.1M-1.2%	-$126.5M-0.7%	-$125.7M-3.1%	-$121.9M-1.6%	-$120.1M-1.5%	-$118.2M-1.3%	-$116.7M-2.2%	-$114.2M-2.0%	-$112.0M

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Total Assets	$16.6M-4.9%	$17.2M-2.2%	$17.8M+3.9%	$17.8M+6.8%	$17.5M+10.0%	$17.6M+4.4%	$17.2M+1.5%	$16.7M+3.2%
Current Assets	$3.5M-23.1%	$3.9M-14.1%	$4.6M-7.2%	$5.0M-3.9%	$4.6M+5.5%	$4.6M-11.2%	$5.0M-13.4%	$5.2M-5.1%
Cash & Equivalents	$1.2M-35.7%	$1.3M-18.1%	$1.7M-12.9%	$1.7M-30.4%	$1.9M-15.1%	$1.6M-30.5%	$1.9M-27.6%	$2.4M-18.1%
Short-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0
Inventory	$645K-3.9%	$832K+15.0%	$875K+6.6%	$1.0M+24.2%	$671K-4.1%	$724K-22.6%	$821K-11.5%	$845K+14.1%
Accounts Receivable	$1.2M-27.9%	$1.3M-24.7%	$1.4M-6.8%	$2.0M+33.9%	$1.7M+52.5%	$1.7M+24.7%	$1.5M+3.5%	$1.5M+6.5%
Long-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0
Goodwill	$1.4M0.0%	$1.4M0.0%	$1.4M0.0%	$1.4M0.0%	$1.4M0.0%	$1.4M0.0%	$1.4M0.0%	$1.4M0.0%
Total Liabilities	$14.8M+11.4%	$14.5M+9.9%	$14.1M+10.4%	$13.8M+8.5%	$13.2M+9.5%	$13.2M+3.5%	$12.8M-0.4%	$12.7M+4.6%
Current Liabilities	$4.2M+34.9%	$4.4M-4.0%	$4.0M+19.4%	$3.7M+12.8%	$3.1M-53.6%	$4.6M-36.8%	$3.3M+1.7%	$3.3M-7.7%
Non-Current Liabilities	$10.6M+4.2%	$10.1M+17.5%	$10.2M+7.2%	$10.1M+7.1%	$10.1M+88.0%	$8.6M+57.7%	$9.5M-1.1%	$9.4M+9.8%
Long-Term Debt	N/A	N/A	$1.9M-12.5%	N/A	N/A	N/A	$2.2M+7.9%	N/A
Total Equity	$1.9M-55.6%	$2.6M-39.0%	$3.7M-15.1%	$4.1M+1.5%	$4.3M+11.4%	$4.3M+7.5%	$4.3M+7.7%	$4.0M-1.1%
Retained Earnings	-$130.5M-2.2%	-$129.6M-1.7%	-$128.2M-0.7%	-$127.8M-0.2%	-$127.6M+0.1%	-$127.4M0.0%	-$127.3M0.0%	-$127.6M-0.3%

INIS Cash Flow Statement

INIS quarterly cash flow statement

Metric	TTM	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Operating Cash Flow	-$376K	$620K-2.9%	$639K+9.6%	$583K+138.9%	-$1.5M-825.0%	-$162K-114.1%	$1.1M+2246.5%	-$54K-155.1%	$97K+120.9%	-$466K-43.7%	-$324K-195.5%	$340K-0.1%	$340K+124.4%	-$1.4M+49.0%	-$2.7M-4186.7%	$67K
Depreciation & Amortization	N/A	$402K+0.3%	$401K+14.6%	$350K-6.4%	$374K-35.6%	$581K+93.7%	$300K+12.0%	$268K+0.1%	$268K+10.9%	$241K+6.4%	$227K+7.4%	$211K-19.9%	$264K-36.6%	$416K+0.1%	$415K+5.6%	$393K
Stock-Based Compensation	N/A	$118K-40.9%	$199K-57.0%	$464K+31.7%	$352K+316.8%	$85K-4.1%	$88K-32.1%	$130K-31.1%	$188K+15.0%	$164K+152.9%	$65K-56.0%	$147K-39.5%	$244K-30.1%	$349K+21.8%	$286K-79.7%	$1.4M
Capital Expenditures	$549K	$534K-25.9%	$721K+383.8%	$149K+24.2%	$120K-41.6%	$205K+2553.3%	$8K-96.3%	$208K+141.1%	$86K-21.6%	$110K+17.6%	$94K+0.8%	$93K-19.6%	$115K	N/A	N/A	N/A
Free Cash Flow	-$925K	$86K+204.3%	-$82K-119.0%	$434K+126.8%	-$1.6M-340.3%	-$367K-132.2%	$1.1M+536.4%	-$262K-2514.1%	$11K+101.9%	-$576K-37.8%	-$418K-269.3%	$247K+10.0%	$224K	N/A	N/A	N/A
Investing Cash Flow	-$549K	-$534K+22.0%	-$685K-359.7%	-$149K-103.8%	$3.9M+1988.3%	-$205K-827.2%	$28K+113.7%	-$206K-139.1%	-$86K-207.7%	$80K+209.8%	-$73K+75.3%	-$296K-642.7%	-$40K+91.7%	-$480K+68.5%	-$1.5M+54.2%	-$3.3M
Financing Cash Flow	$319K	-$276K-89.9%	-$145K-80.4%	-$81K+82.9%	-$472K-499.7%	-$79K+87.6%	-$637K-3221.2%	$20K-89.2%	$189K-78.3%	$871K+177.5%	$314K+253.4%	-$205K-3.4%	-$198K-111.1%	$1.8M-34.0%	$2.7M+138.4%	$1.1M

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Operating Cash Flow	-$614K-294.4%	-$72K-1315.2%	$410K+481.2%	-$100K-135.9%	$316K+354.8%	-$5K-101.2%	$71K+161.3%	$280K+192.3%
Depreciation & Amortization	$107K+6.0%	$110K+12.5%	$103K+2.9%	$101K-0.1%	$101K+2.1%	$98K-3.5%	$100K+13.4%	$101K+16.3%
Stock-Based Compensation	N/A	$244K+247.3%	N/A	N/A	N/A	$70K+12.2%	N/A	N/A
Capital Expenditures	$0-100.0%	$205K+59.2%	$280K-38.4%	$64K+45.4%	$61K+39.7%	$129K-24.6%	$454K+13.0%	$44K-90.9%
Free Cash Flow	-$614K-341.5%	-$278K-107.2%	$130K+134.0%	-$164K-169.8%	$254K+251.4%	-$134K-155.5%	-$383K+25.8%	$236K+129.9%
Investing Cash Flow	$0+100.0%	-$205K-59.2%	-$280K+38.4%	-$64K-22.2%	-$61K-667.2%	-$129K+24.6%	-$454K-213.0%	-$52K+89.2%
Financing Cash Flow	$476K+2003.8%	-$57K+62.3%	-$72K-165.6%	-$28K-3.8%	-$25K+8.7%	-$151K-136.6%	-$27K+94.4%	-$27K-106.4%

Not reported in any period shown, so not listed: Dividends Paid, Share Buybacks.

INIS Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

INIS quarterly financial ratios

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Gross Margin	58.9%-3.3pp	62.2%+2.1pp	60.2%+3.9pp	56.3%-3.1pp	59.4%+1.1pp	58.3%+6.2pp	52.1%+6.9pp	45.2%+1.6pp	43.6%+0.2pp	43.4%+5.1pp	38.3%-1.2pp	39.5%	N/A	N/A	N/A
Operating Margin	-7.3%-7.4pp	0.1%+6.4pp	-6.3%+4.4pp	-10.8%-3.7pp	-7.0%-2.6pp	-4.4%+1.8pp	-6.2%-3.4pp	-2.8%+25.0pp	-27.8%-4.9pp	-22.9%-2.5pp	-20.4%-10.0pp	-10.4%	N/A	N/A	N/A
Net Margin	-7.0%-7.0pp	0.1%+7.1pp	-7.1%-9.8pp	2.7%+12.0pp	-9.3%-32.9pp	23.5%+40.5pp	-17.0%-8.9pp	-8.2%+42.5pp	-50.6%-21.9pp	-28.7%-2.9pp	-25.8%-5.3pp	-20.5%	N/A	N/A	N/A
Return on Equity	-24.6%-24.8pp	0.2%+21.7pp	-21.5%-28.5pp	7.0%+40.0pp	-33.0%-417.1pp	384.0%	N/A	N/A	N/A	-110.1%-58.4pp	-51.7%-12.1pp	-39.6%+11.9pp	-51.5%-14.0pp	-37.5%+44.0pp	-81.5%
Return on Assets	-5.1%-5.1pp	0.1%+5.2pp	-5.1%-7.0pp	1.9%+7.4pp	-5.5%-18.4pp	12.9%+22.9pp	-10.0%-3.5pp	-6.5%+24.8pp	-31.3%-14.8pp	-16.5%-0.3pp	-16.2%-2.1pp	-14.1%+6.4pp	-20.5%-1.9pp	-18.6%+31.3pp	-49.9%
Current Ratio	1.16-0.3x	1.50-0.3x	1.76+0.1x	1.63+1.0x	0.660.0x	0.71-0.1x	0.77+0.1x	0.660.0x	0.68+0.2x	0.44-0.8x	1.26+0.2x	1.05-1.1x	2.13+0.3x	1.82+0.4x	1.42
Debt-to-Equity	0.520.0x	0.510.0x	0.51+0.1x	0.39-0.3x	0.72-2.1x	2.85	N/A	N/A	N/A	2.33+1.3x	1.03+1.0x	0.050.0x	0.05+0.1x	0.00-0.6x	0.62
Asset Turnover	0.73-0.1x	0.81+0.1x	0.730.0x	0.69+0.1x	0.590.0x	0.550.0x	0.59-0.2x	0.80+0.2x	0.620.0x	0.58-0.1x	0.63-0.1x	0.69	N/A	N/A	N/A
FCF Margin	0.7%+1.3pp	-0.6%-4.1pp	3.5%+18.0pp	-14.5%-10.7pp	-3.8%-16.0pp	12.2%+15.1pp	-2.9%-3.0pp	0.1%+7.9pp	-7.8%-1.4pp	-6.4%-9.9pp	3.5%+0.5pp	3.0%	N/A	N/A	N/A

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Gross Margin	50.9%-7.7pp	48.4%-14.4pp	54.8%-4.5pp	59.2%-3.2pp	58.6%-5.1pp	62.7%-1.5pp	59.4%-3.0pp	62.4%+1.0pp
Operating Margin	-31.2%-27.5pp	-55.1%-53.1pp	-19.8%-26.8pp	-5.5%-10.1pp	-3.7%+2.0pp	-2.0%+7.2pp	7.0%+9.9pp	4.6%+15.2pp
Net Margin	-33.0%-28.6pp	-56.7%-53.2pp	-14.9%-21.2pp	-6.2%-10.0pp	-4.4%+3.0pp	-3.5%+1.8pp	6.3%+9.8pp	3.8%+15.8pp
Return on Equity	-46.6%-42.8pp	-50.9%-48.3pp	-11.7%-17.3pp	-5.0%-8.7pp	-3.8%+2.3pp	-2.6%+1.2pp	5.7%+8.4pp	3.7%+12.3pp
Return on Assets	-5.3%-4.4pp	-7.8%-7.2pp	-2.4%-3.9pp	-1.1%-2.0pp	-0.9%+0.5pp	-0.6%+0.3pp	1.4%+2.1pp	0.9%+3.0pp
Current Ratio	0.84-0.6x	0.88-0.1x	1.16-0.3x	1.35-0.2x	1.47+0.8x	0.98+0.3x	1.50-0.3x	1.580.0x
Debt-to-Equity	7.80+4.7x	5.49+2.4x	0.520.0x	3.36+0.2x	3.10-0.1x	3.05-0.1x	0.510.0x	3.14+0.2x
Asset Turnover	0.160.0x	0.140.0x	0.16-0.1x	0.18-0.1x	0.210.0x	0.180.0x	0.230.0x	0.23+0.1x
FCF Margin	-23.0%-29.9pp	-11.7%-7.5pp	4.5%+14.3pp	-5.0%-11.0pp	7.0%+12.3pp	-4.1%-12.5pp	-9.8%+6.6pp	6.0%+33.0pp

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.

Company	Fiscal year	Revenue	Net income	Net margin	Market cap	Health score
RADNOSTIX INC INIS	FY2025	$13.1M	-$908K	-7.0%	$23.8M	—
LEEF BRANDS INC LEEEF	FY2025	$34.8M	-$17.6M	-50.7%	$49.7M	—
EAGLE PHARMS INC EGRX	FY2022	$316.6M	$35.6M	11.3%	$3.3M	—
C21 INVESTMENTS INC CXXIF	FY2026	$32.6M	-$3.2M	-10.0%	$31.4M	—

Where RADNOSTIX INC Ranks

Frequently Asked Questions

What is RADNOSTIX INC's annual revenue?

RADNOSTIX INC (INIS) reported $13.1M in total revenue for fiscal year 2025. This represents a -6.0% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is RADNOSTIX INC's revenue growing?

RADNOSTIX INC (INIS) revenue declined by 6.0% year-over-year, from $13.9M to $13.1M in fiscal year 2025.

Is RADNOSTIX INC profitable?

No, RADNOSTIX INC (INIS) reported a net income of -$908K in fiscal year 2025, with a net profit margin of -7.0%.

What is RADNOSTIX INC's EBITDA?

RADNOSTIX INC (INIS) had EBITDA of -$554K in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

How much debt does RADNOSTIX INC have?

As of fiscal year 2025, RADNOSTIX INC (INIS) had $1.7M in cash and equivalents against $1.9M in long-term debt.

What is RADNOSTIX INC's gross margin?

RADNOSTIX INC (INIS) had a gross margin of 58.9% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

What is RADNOSTIX INC's operating margin?

RADNOSTIX INC (INIS) had an operating margin of -7.3% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

What is RADNOSTIX INC's net profit margin?

RADNOSTIX INC (INIS) had a net profit margin of -7.0% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

What is RADNOSTIX INC's return on equity (ROE)?

RADNOSTIX INC (INIS) has a return on equity of -24.6% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is RADNOSTIX INC's free cash flow?

RADNOSTIX INC (INIS) generated $86K in free cash flow during fiscal year 2025. This represents a 204.3% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is RADNOSTIX INC's operating cash flow?

RADNOSTIX INC (INIS) generated $620K in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are RADNOSTIX INC's total assets?

RADNOSTIX INC (INIS) had $17.8M in total assets as of fiscal year 2025, including both current and long-term assets.

What are RADNOSTIX INC's capital expenditures?

RADNOSTIX INC (INIS) invested $534K in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

How much does RADNOSTIX INC spend on research and development?

RADNOSTIX INC (INIS) invested $436K in research and development during fiscal year 2025.

How many shares does RADNOSTIX INC have outstanding?

RADNOSTIX INC (INIS) had 528M shares outstanding as of fiscal year 2025.

What is RADNOSTIX INC's current ratio?

RADNOSTIX INC (INIS) had a current ratio of 1.16 as of fiscal year 2025, which is considered adequate.

What is RADNOSTIX INC's debt-to-equity ratio?

RADNOSTIX INC (INIS) had a debt-to-equity ratio of 0.52 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is RADNOSTIX INC's return on assets (ROA)?

RADNOSTIX INC (INIS) had a return on assets of -5.1% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is RADNOSTIX INC's P/E ratio?

RADNOSTIX INC (INIS) has no price-to-earnings ratio at the moment: net loss, so no earnings multiple (trailing 12 months to June 30, 2026). The market capitalization is $23.8M as of Oct 15, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

What is RADNOSTIX INC's price-to-sales ratio?

RADNOSTIX INC (INIS) trades at 2.1x sales, its market capitalization divided by revenue of $11.2M revenue, trailing 12 months to June 30, 2026. The market capitalization is $23.8M as of Oct 15, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

What is RADNOSTIX INC's Altman Z-Score?

RADNOSTIX INC (INIS) has an Altman Z-Score of -8.45, placing it in the Distress Zone (elevated bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

What is RADNOSTIX INC's Piotroski F-Score?

RADNOSTIX INC (INIS) has a Piotroski F-Score of 3 out of 9, indicating weak financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are RADNOSTIX INC's earnings high quality?

RADNOSTIX INC (INIS) reported a net loss of $908K while generating $620K in operating cash flow. Operations generated cash despite the loss, but with no positive earnings behind it, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Can RADNOSTIX INC cover its interest payments?

RADNOSTIX INC (INIS) reported an operating loss of $956K against $339K in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.